Open access en Clinical & Translational Oncology (CTO)la Guía SEOM-TTCC de cáncer de cabeza y cuello (2025). Protocolo de práctica clínica de referencia que recoge la evidencia disponible y las opciones terapéuticas en España. @_SEOM @FundacionTTCC
carcinogenicity of e-cigarettes: a qualitative risk assessment
The carcinogenicity of e-cigarettes: a qualitative risk assessment
Considering carcinogenic risk for vapers in comparison with never-users, findings 2017–25 from all types of investigat...
academic.oup.com
Proton beam therapy for oropharyngeal cancer (TORPEdO): a phase 3, randomised controlled trial - The Lancet
Proton beam therapy for oropharyngeal cancer (TORPEdO): a phase 3, randomised controlled trial
IMPT and IMRT had similar late physical quality of life scores, gastrostomy-tube dependence, local control, and overal...
www.thelancet.com
Open access en Clinical & Translational Oncology (CTO)la Guía SEOM-TTCC de cáncer de cabeza y cuello (2025). Protocolo de práctica clínica de referencia que recoge la evidencia disponible y las opciones terapéuticas en España. @_SEOM @FundacionTTCC
carcinogenicity of e-cigarettes: a qualitative risk assessment
The carcinogenicity of e-cigarettes: a qualitative risk assessment
Considering carcinogenic risk for vapers in comparison with never-users, findings 2017–25 from all types of investigat...
academic.oup.com
Proton beam therapy for oropharyngeal cancer (TORPEdO): a phase 3, randomised controlled trial - The Lancet
Proton beam therapy for oropharyngeal cancer (TORPEdO): a phase 3, randomised controlled trial
IMPT and IMRT had similar late physical quality of life scores, gastrostomy-tube dependence, local control, and overal...
www.thelancet.com
Open access en Clinical & Translational Oncology (CTO)la Guía SEOM-TTCC de cáncer de cabeza y cuello (2025). Protocolo de práctica clínica de referencia que recoge la evidencia disponible y las opciones terapéuticas en España. @_SEOM @FundacionTTCC
carcinogenicity of e-cigarettes: a qualitative risk assessment
The carcinogenicity of e-cigarettes: a qualitative risk assessment
Considering carcinogenic risk for vapers in comparison with never-users, findings 2017–25 from all types of investigat...
academic.oup.com
Proton beam therapy for oropharyngeal cancer (TORPEdO): a phase 3, randomised controlled trial - The Lancet
Proton beam therapy for oropharyngeal cancer (TORPEdO): a phase 3, randomised controlled trial
IMPT and IMRT had similar late physical quality of life scores, gastrostomy-tube dependence, local control, and overal...
www.thelancet.com
TTCC en cifras
